Use of Radiesse in Combination With Restylane for Facial Augmentation

Abstract

To report the long-term results of 72 consecutive patients treated with Radiesse (BioForm Inc, Franksville, Wis) and 29 patients treated with Radiesse and Restylane (Q-Medical, Uppsala, Sweden) and to share recommendations based on our experience. Methods: A total of 72 patients were treated with Radiesse between October 2003 and December 2004. Of these patients, 29 also received Restylane for facial augmentation. Forty-six Radiesse-treated and 15 Radiesse and Restylanetreated patients completed questionnaires detailing their experience with the procedure, postoperative sequelae, overall satisfaction, and satisfaction at each site treated. Results: On a 10-point scale, the overall satisfaction with Radiesse averaged 7.6, and 30 patients (65%) would recommend this procedure to others. Of the 72 patients, 2 (3%) reported persistent nodules, and both required removal of a small amount of the material. The overall satisfaction with the Radiesse and Restylane-combined treatment averaged 8.1, and 12 patients (79%) would recommend this procedure to others. No patients reported persistent nodules. Conclusions: The use of Radiesse and Restylane in combination is an excellent option for facial enhancement. With long-term experience, complications in the lip area with RadiessetreatmentarenowavoidedwiththeuseofRestylane. In contrast to patients treated with Radiesse alone, the combination treatment group in this study tended to have greater immediateandoverallsatisfactionscoresandwasmorelikely to recommend the combination procedure to others.

Use of calcium hydroxylapatite (Radiesse^®) for facial augmentation

“…Godin and colleagues presented an interesting study in which Radiesse and non-animal hyaluronic acid are combined to improve facial enhancement (Godin et al 2006). Many patients have received semipermanent fillers after temporary fillers without interference (Lemperle et al 2006).…”

Clinical data on injectable tissue fillers: a review

“…for three subjects the follow-up period was 36 months or more, for nine subjects the follow-up was less than 12 months). [110] Prospective study (n = 40), 18 months follow-up Ecchymosis and hematoma occurred in 2 of the subjects Treatment related [111] Prospective study (n = 100), 18 months follow-up…”

A New Classification of Lip Zones to Customize Injectable Lip Augmentation

“…This correlates well with other studies. [16][17][18] Aside from transient erythema at the injection sites and infrequent bruising, these patients were free of adverse effects. European studies show satisfactory results with NASHA gel used as a temporary soft-tissue expander.…”